MD&A Q120269 Feb 2026 11:42
The Q1 FY2026 MD&A, approved in mid-November 2025, states that SolGold had around US$34m of cash at bank and, after considering downside scenarios and mitigations, adequate resources for at least 15 months taking the runway well into early 2027. Importantly, FN Tranche 3 is not included as cash and is treated as conditional upside, not as a prerequisite for survival. Against that backdrop, it is notable that neither the Scheme Document nor today’s RNS explains why shareholders are now being presented with a far more compressed and cautionary funding narrative, including suggestions of near term funding pressure by Q2 2026 if the Scheme fails. There is no reconciliation of this change in emphasis, no statement that circumstances have materially deteriorated since the MD&A, and no update on expected news items such as CIPA or Hole 77, leaving shareholders to assess an irreversible proposal without clarity as to why previously stated runway and optionality are no longer reflected. Can I ask what is exactly is going on at Solgold? There's the evidence right there from the actual documents, the Q12026 MD&A , the SD and today's RNS. Do you know, Needy?